B-cell development and functions and therapeutic options in adenosine deaminase–deficient patients-Reference-Cited by-同舟云学术

B-cell development and functions and therapeutic options in adenosine deaminase–deficient patients

Published:2014-03 Issue:3 Volume:133 Page:799-806.e10
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Brigida Immacolata,Sauer Aisha V.,Ferrua Francesca,Giannelli Stefania,Scaramuzza Samantha,Pistoia Valentina,Castiello Maria Carmina,Barendregt Barbara H.,Cicalese Maria Pia,Casiraghi Miriam,Brombin Chiara,Puck Jennifer,Müller Klaus,Notarangelo Lucia Dora,Montin Davide,van Montfrans Joris M.,Roncarolo Maria Grazia,Traggiai Elisabetta,van Dongen Jacques J.M.,van der Burg Mirjam,Aiuti Alessandro

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference47 articles.

1. Immunodeficiency due to defects of purine metabolism;Hirschhorn,2006

2. Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency;Sauer;Front Immunol,2012

3. Outcome of hematopoietic stem cell transplantation for adenosine deaminase deficient severe combined immunodeficiency;Hassan;Blood,2012

4. Gene therapy for childhood immunological diseases;Kohn;Bone Marrow Transplant,2008

5. Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID;Sauer;Blood,2012

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomal RNA—an introduction;Exosomal RNA;2024

2. Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clones;Molecular Therapy - Methods & Clinical Development;2021-12

3. Normal IgH Repertoire Diversity in an Infant with ADA Deficiency After Gene Therapy;Journal of Clinical Immunology;2021-06-28

4. Circular RNAs and Its Biological Functions in Health and Disease;Gene Expression and Phenotypic Traits;2020-04-01

5. Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy;Clinical Immunology;2020-02